Interobserver variability in the evaluation of mismatch repair protein immunostaining

Louise Klarskov; Steen Ladelund; Susanne Holck; Karina Roenlund; Jan Lindebjerg; Jacob Elebro; Britta Halvarsson; Jenny von Salomé; Inge Bernstein; Mef Nilbert

doi:10.1016/j.humpath.2010.03.003

Interobserver variability in the evaluation of mismatch repair protein immunostaining

Louise Klarskov, Steen Ladelund, Susanne Holck, Karina Roenlund, Jan Lindebjerg, Jacob Elebro, Britta Halvarsson, Jenny von Salomé, Inge Bernstein, Mef Nilbert

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

55 Citationer (Scopus)

Abstract

Udgivelsesdato: 2010-Okt

Originalsprog	Engelsk
Tidsskrift	Human Pathology
Vol/bind	41
Udgave nummer	10
Sider (fra-til)	1387-1396
Antal sider	10
ISSN	0046-8177
DOI	https://doi.org/10.1016/j.humpath.2010.03.003
Status	Udgivet - 2010

Bibliografisk note

Adgang til dokumentet

10.1016/j.humpath.2010.03.003

Citationsformater

@article{7191a9a1e81d49a78b756c2a73dfb175,

title = "Interobserver variability in the evaluation of mismatch repair protein immunostaining",

abstract = "Immunohistochemical staining for mismatch repair proteins has during recent years been established as a routine analysis in many pathology laboratories with the aim to identify tumors linked to the hereditary nonpolyposis colorectal cancer syndrome. Despite widespread application, data on reliability are lacking. We therefore evaluated interobserver variability among 6 pathologists, 3 experienced gastrointestinal pathologists and 3 residents. In total, 225 immunohistochemically stained colorectal cancers were evaluated as having normal, weak, loss of, or nonevaluable mismatch repair protein staining. Full consensus was achieved in 51% of the stainings for MLH1, 61% for PMS2, 83% for MSH2, and 45% for MSH6. Weak stainings were the main cause of reduced consensus, whereas contradictory evaluations with normal as well as loss of staining were reported in 2% to 6% of the tumors. Interobserver variability was considerable, though experienced pathologists and residents reached the same level of consensus. Because results from immunohistochemical mismatch repair protein stainings are used for decisions on mutation analysis and as an aid in the interpretation of gene variants of unknown significance in hereditary nonpolyposis colorectal cancer, the interobserver variability identified highlights the need for quality assessment programs, including guidelines for classification of different expression patterns.",

author = "Louise Klarskov and Steen Ladelund and Susanne Holck and Karina Roenlund and Jan Lindebjerg and Jacob Elebro and Britta Halvarsson and {von Salom{\'e}}, Jenny and Inge Bernstein and Mef Nilbert",

year = "2010",

doi = "10.1016/j.humpath.2010.03.003",

language = "English",

volume = "41",

pages = "1387--1396",

journal = "Human Pathology",

issn = "0046-8177",

publisher = "W.B.Saunders Co.",

number = "10",

}

TY - JOUR

T1 - Interobserver variability in the evaluation of mismatch repair protein immunostaining

AU - Klarskov, Louise

AU - Ladelund, Steen

AU - Holck, Susanne

AU - Roenlund, Karina

AU - Lindebjerg, Jan

AU - Elebro, Jacob

AU - Halvarsson, Britta

AU - von Salomé, Jenny

AU - Bernstein, Inge

AU - Nilbert, Mef

PY - 2010

Y1 - 2010

N2 - Immunohistochemical staining for mismatch repair proteins has during recent years been established as a routine analysis in many pathology laboratories with the aim to identify tumors linked to the hereditary nonpolyposis colorectal cancer syndrome. Despite widespread application, data on reliability are lacking. We therefore evaluated interobserver variability among 6 pathologists, 3 experienced gastrointestinal pathologists and 3 residents. In total, 225 immunohistochemically stained colorectal cancers were evaluated as having normal, weak, loss of, or nonevaluable mismatch repair protein staining. Full consensus was achieved in 51% of the stainings for MLH1, 61% for PMS2, 83% for MSH2, and 45% for MSH6. Weak stainings were the main cause of reduced consensus, whereas contradictory evaluations with normal as well as loss of staining were reported in 2% to 6% of the tumors. Interobserver variability was considerable, though experienced pathologists and residents reached the same level of consensus. Because results from immunohistochemical mismatch repair protein stainings are used for decisions on mutation analysis and as an aid in the interpretation of gene variants of unknown significance in hereditary nonpolyposis colorectal cancer, the interobserver variability identified highlights the need for quality assessment programs, including guidelines for classification of different expression patterns.

AB - Immunohistochemical staining for mismatch repair proteins has during recent years been established as a routine analysis in many pathology laboratories with the aim to identify tumors linked to the hereditary nonpolyposis colorectal cancer syndrome. Despite widespread application, data on reliability are lacking. We therefore evaluated interobserver variability among 6 pathologists, 3 experienced gastrointestinal pathologists and 3 residents. In total, 225 immunohistochemically stained colorectal cancers were evaluated as having normal, weak, loss of, or nonevaluable mismatch repair protein staining. Full consensus was achieved in 51% of the stainings for MLH1, 61% for PMS2, 83% for MSH2, and 45% for MSH6. Weak stainings were the main cause of reduced consensus, whereas contradictory evaluations with normal as well as loss of staining were reported in 2% to 6% of the tumors. Interobserver variability was considerable, though experienced pathologists and residents reached the same level of consensus. Because results from immunohistochemical mismatch repair protein stainings are used for decisions on mutation analysis and as an aid in the interpretation of gene variants of unknown significance in hereditary nonpolyposis colorectal cancer, the interobserver variability identified highlights the need for quality assessment programs, including guidelines for classification of different expression patterns.

U2 - 10.1016/j.humpath.2010.03.003

DO - 10.1016/j.humpath.2010.03.003

M3 - Journal article

SN - 0046-8177

VL - 41

SP - 1387

EP - 1396

JO - Human Pathology

JF - Human Pathology

IS - 10

ER -